SUNBRIGHT PP-020CN (DPPE-PEG2000) can be applied to lipid nanoparticle (LNP) and liposomal formulations to modulate particle stability and circulation time in the bloodstream. Due to its intermediate fatty acid chain length (C16), PP-020CN exhibits moderate membrane anchoring strength, controlling a balance between stability in circulation and PEG shedding.
